Sign In

Login

Password

Forgot Password ? Sign Up

Timozin α1 (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Timozin α1" in Serbian language version.

refsWebsite
Global rank Serbian rank
6nih.gov
4th place
8th place
6doi.org
2nd place
4th place

doi.org

  • Elizondo-Riojas, M. A.; Chamow, S. M.; Tuthill, C. W.; Gorenstein, D. G.; Volk, D. E. (2011). „NMR structure of human thymosin alpha-1”. Biochemical and Biophysical Research Communications. 416 (3–4): 356—361. PMID 22115779. doi:10.1016/j.bbrc.2011.11.041. 
  • Manrow RE, Leone A, Krug MS, Eschenfeldt WH, Berger SL (1992). „The human prothymosin alpha gene family contains several processed pseudogenes lacking deleterious lesions”. Genomics. 13 (2): 319—31. PMID 1612591. doi:10.1016/0888-7543(92)90248-Q. 
  • Garaci E (2007). „Thymosin alpha1: a historical overview”. Ann. N. Y. Acad. Sci. 1112: 14—20. PMID 17567941. doi:10.1196/annals.1415.039. 
  • Wara DW, Goldstein AL, Doyle NE, Ammann AJ (1975). „Thymosin activity in patients with cellular immunodeficiency”. N. Engl. J. Med. 292 (2): 70—4. PMID 1078552. doi:10.1056/NEJM197501092920204. 
  • Garaci E; Favalli C; Pica F; et al. (2007). „Thymosin alpha 1: from bench to bedside”. Ann. N. Y. Acad. Sci. 1112: 225—34. PMID 17600290. doi:10.1196/annals.1415.044. 
  • Goldstein AL, Goldstein AL (2009). „From lab to bedside: emerging clinical applications of thymosin alpha 1”. Expert Opin Biol Ther. 9 (5): 593—608. PMID 19392576. doi:10.1517/14712590902911412. 

nih.gov

ncbi.nlm.nih.gov

  • Elizondo-Riojas, M. A.; Chamow, S. M.; Tuthill, C. W.; Gorenstein, D. G.; Volk, D. E. (2011). „NMR structure of human thymosin alpha-1”. Biochemical and Biophysical Research Communications. 416 (3–4): 356—361. PMID 22115779. doi:10.1016/j.bbrc.2011.11.041. 
  • Manrow RE, Leone A, Krug MS, Eschenfeldt WH, Berger SL (1992). „The human prothymosin alpha gene family contains several processed pseudogenes lacking deleterious lesions”. Genomics. 13 (2): 319—31. PMID 1612591. doi:10.1016/0888-7543(92)90248-Q. 
  • Garaci E (2007). „Thymosin alpha1: a historical overview”. Ann. N. Y. Acad. Sci. 1112: 14—20. PMID 17567941. doi:10.1196/annals.1415.039. 
  • Wara DW, Goldstein AL, Doyle NE, Ammann AJ (1975). „Thymosin activity in patients with cellular immunodeficiency”. N. Engl. J. Med. 292 (2): 70—4. PMID 1078552. doi:10.1056/NEJM197501092920204. 
  • Garaci E; Favalli C; Pica F; et al. (2007). „Thymosin alpha 1: from bench to bedside”. Ann. N. Y. Acad. Sci. 1112: 225—34. PMID 17600290. doi:10.1196/annals.1415.044. 
  • Goldstein AL, Goldstein AL (2009). „From lab to bedside: emerging clinical applications of thymosin alpha 1”. Expert Opin Biol Ther. 9 (5): 593—608. PMID 19392576. doi:10.1517/14712590902911412.